Economic evaluation of osteoporosis screening strategy conducted in the Province of Liège with the cooperation of Liège Province Santé;Evaluation économique de la campagne de dépistage de l'ostéoporose menée en Province de Liège avec le concours de Liège Province Santé

Revue Medicale de Liege

Volumn 63, Issue 10, 2008, Pages 588-594

  Hiligsmann, M ^a   Bruyere O ^a   Pire, G ^b   Reginster, J Y ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Qualite de Vie et de l'Environnement ^*  (Belgium)

Author keywords

Cost effectiveness; Osteoporosis; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; OSTEOPOROSIS; PROBABILITY; RISK FACTOR; SIMULATION; ULTRASOUND;

AGED; BELGIUM; BONE DENSITY; COST-BENEFIT ANALYSIS; FEMALE; FRACTURES, BONE; HUMANS; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PUBLIC HEALTH; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 54849434083     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hiligsmann M, Bruyère O, Reginster JY. - Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. Rev Med Liege, 2008, 63, 480-487.
2. Report of a WHO Study Group. - Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser, 1994, 843, 1-129.
3. Reginster JY, Dethor M, Pirenne H, et al. - Reproducibility and diagnostic sensitivity of ultrasonometry of the phalanges to assess osteoporosis. Int J Gynaecol Obstet, 1998, 63, 21-28.
4. Cummings SR, Black DM, Thompson DE, et al. - Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA, 1998, 280, 2077-2082.
5. Krieg MA, Cornuz J, Ruffieux C, et al. - Rôle des ultrasons osseux pour la prédiction du risque de fracture de hanche chez la femme âgée de 70 ans ou plus: résultats de l'étude SEMOF et comparaison avec les données de la littérature: Ostéoporose. Rev Med Suisse romande, 2004, 124, 59-62.
6. Richy F, Gourlay M, Ross PD, et al. - Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium. Q J Med, 2004, 97, 39-46.
7. Stevenson M, Davis S. - Analyses of the cost-effectiveness of the pooled alendronate and risedronate, compared with strontium ranelate, raloxifene, etidronate and teriparatide. ScHAAR, 2006.
8. ECODATA, Service Public Fédéral Economie, PME, Classes Moyennes et Energies.
9. Boonen S, Kaufman JM, Reginster JY, et al. - Patient assessment using standardized bone mineral density values and a national reference database : implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium. Osteoporos Int, 2003, 14, 110-115.
10. Raftery J. - NICE : faster access to modern treatments? Analysis of guidance on health technologies. BMJ, 2001, 323, 1300-1303.
11. Kanis JA, Jonsson B. - Economic evaluation of interventions for osteoporosis. Osteoporos Int, 2002, 13, 765-767.
12. Boonen S, Body JJ, Boutsen Y, et al. - Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int, 2005, 16, 239-254.
13. Rabenda V, Mertens R, Fabri V, et al. - Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int, 2008 (sous presse).
14. Kanis J, Burlet N, Cooper C, et al. - European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int, 2008, sous presse.